<h2 id="treatment-outcomes-grouped-by-criminal-justice-status"><strong>Treatment outcomes grouped by criminal justice status</strong></h2>



<h3 id="retention-in-buprenorphine-treatment"><strong>Retention in buprenorphine treatment</strong></h3>



<h4 id="retention-grouped-by-baseline-criminal-justices-status"><strong>Retention grouped by baseline criminal justices status</strong></h4>

<p><strong>Retention by ever incarcerated more than 3 days:</strong></p>

<p><img src="http://danielriggins.com/img/reten_by_baseline_ever_incar.svg" alt="img" title=""></p>

<p><strong>Retention by recent incarceration:</strong></p>

<p><img src="http://danielriggins.com/img/retention_by_baseline_recent_incar.svg" alt="img" title=""></p>

<p><strong>Retention by parole/probation status:</strong></p>

<p><img src="http://danielriggins.com/img/retention_by_baseline_parole.svg" alt="img" title=""></p>

<p>If you only use baseline parole/probation status to predict 3-month retention, the coefficient is -0.62 (p = 0.01). Being on parole or probation decreases the odds of retention by -46% (OR = 0.54).</p>

<p>If you control with ASI drug composite score and having ever injected drugs, the coefficient for parole/probation drops to -0.55 (p = 0.03). In the controlled model, being on parole or probation decreases the odds of retention by -43% (OR = 0.56).</p>